Studies of Kidney Transplant Outcome

• Status: Completed
• Trial end date: 2019-05-06
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Collaborator: Genentech, Inc.
• Treatments: Antilymphocyte Serum; Thymoglobulin

Criteria

Inclusion Criteria:

• Kidney Transplant Recipient at the University of Minnesota

• Kidney Transplant Recipients on steroid-free maintenance immunosuppression

Exclusion Criteria:

• Non-kidney transplant patients at the University of Minnesota